Human Genetics

, Volume 121, Issue 5, pp 635–637 | Cite as

The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer

  • George Zogopoulous
  • Heidi Rothenmund
  • Ayelet Eppel
  • Colleen Ash
  • Mohammad Reza Akbari
  • David Hedley
  • Steven A. Narod
  • Steven Gallinger
Short Report

Abstract

The P239S palladin variant has recently been suggested to play a role in hereditary pancreatic cancer. We estimated the contribution of the P239S variant, and surrounding sequence, to familial and early-onset pancreatic cancer. The P239S germline variant was identified in one of 84 high-risk cases and one of 555 controls. The case reported an elderly relative with pancreas cancer. We conclude that this variant does not appear to account for a significant fraction of hereditary or early-onset pancreas cancer.

Supplementary material

References

  1. American Cancer Society (2006) Cancer Facts and Figures 2006. American Cancer Society, AtlantaGoogle Scholar
  2. Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB (1999) Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 131:247–255PubMedGoogle Scholar
  3. Canadian Cancer Society/National Cancer Institute of Canada (2006) Canadian Cancer Statistics 2006. Toronto, CanadaGoogle Scholar
  4. Eberle MA, Pfutzer R, Pogue-Geile KL, Bronner MP, Crispin D, Kimmey MB, Duerr RH, Kruglyak L, Whitcomb DC, Brentnall TA (2002) A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32–34. Am J Hum Genet 70:1044–1048PubMedCrossRefGoogle Scholar
  5. Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod SA, Redston M, Gallinger S (2000) Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 60:409–416PubMedGoogle Scholar
  6. Li D, Xie K, Wolff R, Abbruzzese JL (2004) Pancreatic cancer. Lancet 363:1049–1057PubMedCrossRefGoogle Scholar
  7. Pogue-Geile KL, Chen R, Bronner MP, Crnogorac-Jurcevic T, Moyes KW, Dowen S, Otey CA, Crispin DA, George RD, Whitcomb DC, Brentnall TA (2006) Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med 3:e516PubMedCrossRefGoogle Scholar
  8. Ronty M, Taivainen A, Moza M, Otey CA, Carpen O (2004) Molecular analysis of the interaction between palladin and alpha-actinin. FEBS Lett 566:30–34PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • George Zogopoulous
    • 1
    • 2
  • Heidi Rothenmund
    • 1
    • 2
  • Ayelet Eppel
    • 2
  • Colleen Ash
    • 1
  • Mohammad Reza Akbari
    • 3
  • David Hedley
    • 4
  • Steven A. Narod
    • 3
  • Steven Gallinger
    • 1
    • 2
    • 5
  1. 1.Sam Minuk Cancer Genetics and Biomarker LaboratoriesSamuel Lunenfeld Research InstituteTorontoCanada
  2. 2.Familial Gastrointestinal Cancer RegistryMount Sinai HospitalTorontoCanada
  3. 3.Women’s College Research InstituteUniversity of TorontoTorontoCanada
  4. 4.Department of Medical Oncology and Hematology and Division of Experimental Therapeutics, Ontario Cancer Institute/Princess Margaret HospitalUniversity of TorontoTorontoCanada
  5. 5.Mount Sinai HospitalTorontoCanada

Personalised recommendations